ArticleBMJ open2019
Australian pharmacists' perspectives on physician-assisted suicide (PAS): thematic analysis of semistructured interviews.
Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- From legalisation to practice: implementation of newly legalised health interventions in healthcare settings - a systematic review.BMJ open · 2026Pooled it
- Exploring Community Pharmacists' Knowledge of Voluntary Assisted Dying and Authorised Disposal in Australia.Pharmacy (Basel, Switzerland) · 2026Article
- Final destination - pharmacists' perspectives on assisted suicide (the PAS-study): a cross-sectional convergent parallel mixed-methods study.Journal of pharmaceutical policy and practice · 2026Article
- Exploring multiple levels of suffering and suicide prevention in an era of emerging national legislations.Frontiers in public health · 2025Article
- Assisted suicide within long-term care facilities for older adults: organizational issues and processes experienced by health and social care providers in Switzerland.Frontiers in psychiatry · 2025Article
- Policies and cost analyses of voluntary assisted dying (VAD) laws - a mapping review & analysis.Health economics review · 2024Article
- Pharmacists' Attitudes towards Medically Assisted Dying.Pharmacy (Basel, Switzerland) · 2024Article
- Conscientious objection - a cross-sectional, vignette-based, mixed methods exploration of Australian pharmacists' perspectives.Journal of pharmaceutical policy and practice · 2024Article
- Conscientious Objection and Other Motivations for Refusal to Treat in Hastened Death: A Systematic Review.Healthcare (Basel, Switzerland) · 2023Review
- Knowledge and attitudes toward euthanasia among final year pharmacy and law students: a cross-sectional study.Journal of pharmaceutical policy and practice · 2023Article
- Hospital Pharmacists' Experiences with Medical Assistance in Dying: A Qualitative Study.The Canadian journal of hospital pharmacy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to investigate Australian pharmacists' views about their role in physician-assisted suicide (PAS), their ethical and legal concerns and overall thoughts about PAS in pharmacy.
designSemistructured interviews of pharmacists incorporating a previously validated vignette and thematic analysis.
settingAustralia (face to face or phone call).
participants40 Australian Health Practitioner Regulation Agency registered pharmacists, majority women (65%) with varied experiences in community, hospital, industry, academia, government and other fields.
resultsEmergent themes from the interviews were:
conclusionThis study revealed current concerns of practising pharmacists in Australia, including previously undocumented perspectives on the pharmacoeconomic impact of and barriers relating to PAS. The need for training of all healthcare professionals involved, the provision of clear guidelines, including regulation around storage, administration and disposal of medicines dispensed for PAS and the updating of current therapeutic guidelines around end-of-life care were all issues delineated by this study. These findings highlighted the need for current and future policies to account for all stakeholders involved in PAS, not solely prescribers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.